The intracellular selenium status or the bioavailable selenium (hydrogen selenide) depends on the dietary intake of selenium [28,29,30,31,32,33,34]
Make sure that the original product label remains intact and legible, so that it can be confirmed that the vial contains bacteriostatic water for injection
In general, GLP-1 coverage for obesity treatment has been more variable compared to that of diabetes management because obesity has historically not been recognized as a legitimate metabolic disease
Most common GLP-1 side effects The most common side effects of Semaglutide (GLP-1) medications include nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)